tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (FR:SAN)
:SAN
France Market
SAN
Sanofi
RESEARCH TOOLSreports

Sanofi (SAN) Stock News & Sentiment

Compare
275 Followers
Sanofi’s ITP Burden Study Completes, Adding Real‑World Insight for Investors
Premium
Company Announcements
Sanofi’s ITP Burden Study Completes, Adding Real‑World Insight for Investors
2d ago
SNYNF
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
Premium
Ratings
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
14d ago
SNY
Sanofi’s SAR445399 Study: A Potential Breakthrough in Hidradenitis Suppurativa Treatment
Premium
Company Announcements
Sanofi’s SAR445399 Study: A Potential Breakthrough in Hidradenitis Suppurativa Treatment
14d ago
SNYNF
Sanofi’s Amlitelimab Study: A New Hope for Atopic Dermatitis Treatment?
Premium
Company Announcements
Sanofi’s Amlitelimab Study: A New Hope for Atopic Dermatitis Treatment?
14d ago
SNYNF
Sanofi’s Amlitelimab Study Termination: Implications for Investors
Premium
Company Announcements
Sanofi’s Amlitelimab Study Termination: Implications for Investors
14d ago
SNYNF
Sanofi’s Dupilumab Study Completion: Implications for Asthma Treatment and Market Impact
Premium
Company Announcements
Sanofi’s Dupilumab Study Completion: Implications for Asthma Treatment and Market Impact
14d ago
SNYNF
Sanofi’s Undervalued Stock and Growth Prospects Drive Buy Rating Despite Near-Term Challenges
Premium
Ratings
Sanofi’s Undervalued Stock and Growth Prospects Drive Buy Rating Despite Near-Term Challenges
28d ago
SNY
More FR:SAN News >

SAN News on the Web

The Club's top 10 things to watch in the stock market Wednesday
CNBC
Neutral
European markets poised for lackluster open ahead of shortened trading session
CNBC
Neutral
Sanofi To Commence Cash Tender Offer To Acquire Dynavax For $15.50/share
rttnews
Neutral
FDA Issues Complete Response Letter For Sanofi's Tolebrutinib In NrSPMS Review
rttnews
Neutral
Sanofi Wins EU Approval For Wayrilz In Immune Thrombocytopenia
rttnews
Neutral
Sanofi: Dupixent Now Approved In Japan For Children Aged 6 To 11 Years
rttnews
Neutral
Nine of the largest pharma companies ink deals with Trump to lower drug prices
CNBC
Neutral
Leerink Partners Reaffirms Their Buy Rating on Sanofi (SNYNF)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
FR:SAN
Sector Average
Media Buzz
This Week6 articles
Weekly Average4.5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?
6 articles about FR:SAN were published this week. In an average week, 4.5 articles are published.
    What is FR:SAN’s weekly average amount of articles?
    In an average week, 4.5 articles about FR:SAN are published.
      What is FR:SAN’s News Sentiment?
      50% of articles about FR:SAN were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        DVAXDynavax
        AGIOAgios Pharma
        ADUSAddus Homecare
        EWTXEdgewise Therapeutics
        MASIMasimo
        Showing the stocks with the most bullish news sentiment over the past week